Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.6 |
mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |